Home Drug Codes J Codes J9051 · BORTEZOMIB (MAIA)
Updated July 1st, 2026

BORTEZOMIB (MAIA) J Code: J9051

Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
No current ASP
Not available for Q3 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
1
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg
HCPCS Added Date October 1, 2023
Manufacturer MAIA Pharma
Route of Administration Intravenous
Generic Status Single-Source; Branded

About BORTEZOMIB (MAIA)

Bortezomib (maia) is a medication aligned to the HCPCS J Code: J9051 for billing, pricing, and reimbursement purposes in the United States. This Oncology medication is administered via the intravenous route and manufactured by MAIA Pharma.

Manufacturers, reach out to us to add more information.

NDC Code Information

1 NDC package is crosswalked to J9051. Package detail is available to logged-in subscribers.

Login to view 1 NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

BORTEZOMIB (MAIA) Pricing & Reimbursement

J9051 Private Payer Reimbursement
$3.45 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Bortezomib 505(b)(2) Information:

HCPCS Code Manufacturer Active Ingredient HCPCS Description
J9041 Generic Code (Multiple Manufacturers) Bortezomib Injection, bortezomib, 0.1 mg
J9046 Dr Reddy's Laboratories, Inc Bortezomib Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg
J9048 Fresenius Kabi Bortezomib Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg
J9049 Hospira Bortezomib Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg
J9051 Fosun Pharma Bortezomib Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg
J9054 Log in to view
Log in to view all 6 505(b)(2) codes

BORTEZOMIB (MAIA) CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96409 Chemotherapy administration; intravenous, push technique, single or initial substance/drug
96411 Chemotherapy administration; intravenous, push technique, each additional substance/drug (List separately in addition to code for primary procedure)
JW / JZ modifiers apply

CMS has identified Bortezomib (maia) (J9051) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

BORTEZOMIB (MAIA) Medically Unlikely Edits (MUE)

The most billing units of J9051 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.1 mg.

Practitioner Office & Hospital Outpatient
35 units / day
= 3.5 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

BORTEZOMIB (MAIA) Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Multiple myeloma Mantle cell lymphoma

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Bortezomib (Maia) billing and coding guide?
We have not yet identified a manufacturer source of Bortezomib (Maia) billing and coding information.
Where can I find Bortezomib (Maia) prescribing information?
BORTEZOMIB (MAIA) prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date. Visit Here →
Where can I find Bortezomib (Maia) side effect information?
Our team has not yet identified a source of side effects information for BORTEZOMIB (MAIA). Please check back in a few weeks.
Does billing BORTEZOMIB (MAIA) require JZ/JW wastage modifiers?
CMS has identified BORTEZOMIB (MAIA)(J9051) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.